| Medicinal product name | Salofalk 1000 mg prolonged release granules |
|---|---|
| Pharmaceutical form | Prolonged-release granules |
| Strength | 1000 mg |
| Information from the MAH on shortages |
Not available predicted availability date: not notified |
| Legal status | Prescription (Pr.) |
| Package leaflet |  13-04-2023
|
| Summary of product characteristics | 13-04-2023
|
| ATC code | A07EC02 – Antidiarrheals, intestinal antiinflammatory/antiinfective agents |
| Information for Marketing authorisation holders | View |
Medicinal products (5)
| Availability of medicinal product | Wholesalers | Package size, content | Primary packaging | Maximum admissible pharmacy price (€ incl. VAT) | Product No. | Labelling |
|---|---|---|---|---|---|---|
|
Not available (according to the information provided by wholesalers) predicted availability date: not notified |
currently no information on availability from any wholesaler |
N20 (1000 mg) |
Polyester/Al/PE sachet | 13-0204-01 |
Labelling text Apr 13, 2023 Labelling text Apr 13, 2023 |
|
| Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N50 (1000 mg) |
Polyester/Al/PE sachet | 13-0204-02 |
Labelling text Apr 13, 2023 Labelling text Apr 13, 2023 |
|
| Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N60 (1000 mg) |
Polyester/Al/PE sachet | 13-0204-03 |
Labelling text Apr 13, 2023 Labelling text Apr 13, 2023 |
|
| Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N100 (1000 mg) |
Polyester/Al/PE sachet | 13-0204-04 |
Labelling text Apr 13, 2023 Labelling text Apr 13, 2023 |
|
| Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N150 (1000 mg) |
Polyester/Al/PE sachet | 13-0204-05 |
Labelling text Apr 13, 2023 Labelling text Apr 13, 2023 |
Registration information
| Marketing authorisation No. | 13-0204 |
|---|---|
| Date of authorisation | Sep 25, 2013 |
| Marketing authorisation holder, country | Dr. Falk Pharma GmbH, Germany |
